Jeffrey W. Sherman - Jan 1, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Medical Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 1, 2023
Transactions value $
-$1,105,795
Form type
4
Date filed
1/4/2023, 03:27 PM
Previous filing
Dec 29, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +21.8K +916.72% 24.1K Jan 1, 2023 Direct F1
transaction HZNP Ordinary Shares Tax liability -$1.11M -9.72K -40.24% $113.80 14.4K Jan 1, 2023 Direct
holding HZNP Ordinary Shares 54.5K Jan 1, 2023 See Footnote F2
holding HZNP Ordinary Shares 84.4K Jan 1, 2023 See Footnote F3
holding HZNP Ordinary Shares 66.7K Jan 1, 2023 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Performance Restricted Stock Units (PSUs) Options Exercise $0 -21.8K -100% $0.00* 0 Jan 1, 2023 Ordinary Shares 21.8K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each PSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The shares are held in the Jeffrey W. Sherman Living Trust.
F3 The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
F4 The ordinary shares subject to the PSUs vested on January 1, 2023.